KATHRYN RAY: Open Payments
NPI 1588017743 · LAGRANGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 24 payments from 12 companies in 2025. Trend: 2023 $396 · 2024 $939 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $229 |
| Merck Sharp & Dohme LLC | 4 | $76 |
| SCPHARMACEUTICALS INC. | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Amgen Inc. | 2 | $29 |
| Kestra Medical Technology Services, Inc. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Melinta Therapeutics, LLC | 1 | $25 |
| MEDICOMP INC | 1 | $22 |
| PFIZER INC. | 1 | $20 |
Products named: WAINUA, VERQUVO, FUROSCIX, SHINGRIX, REPATHA, Assure WCD, LEQVIO, Rezzayo.
Industry payments across GA — which companies pay providers there.
